Filter Results:
(937)
Show Results For
- All HBS Web
(1,072)
- People (1)
- News (48)
- Research (937)
- Events (2)
- Multimedia (1)
- Faculty Publications (867)
Show Results For
- All HBS Web
(1,072)
- People (1)
- News (48)
- Research (937)
- Events (2)
- Multimedia (1)
- Faculty Publications (867)
Sort by
- winter 1998
- Article
Negotiating Cross-Border Acquisitions
Sebenius, James K. "Negotiating Cross-Border Acquisitions." MIT Sloan Management Review 39, no. 2 (winter 1998): 27–41. (Reprinted in Cross-Cultural Management, Gordon Redding and Bruce W. Stening, eds., Surrey: Edward Elgar Publishing, 2002.)
- February 2010 (Revised September 2011)
- Case
Roche's Acquisition of Genentech
By: Carliss Y. Baldwin, Bo Becker and Vincent Marie Dessain
Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and... View Details
Keywords: Mergers and Acquisitions; Business Subsidiaries; Negotiation Offer; Organizational Culture; Corporate Strategy; Biotechnology Industry; Pharmaceutical Industry; Switzerland
Baldwin, Carliss Y., Bo Becker, and Vincent Marie Dessain. "Roche's Acquisition of Genentech." Harvard Business School Case 210-040, February 2010. (Revised September 2011.)
- December 2014
- Article
The Real Product Market Impact of Mergers
By: Albert Sheen
I document sources of value creation in mergers by analyzing novel data on the quality and price of goods sold by merging firms. When two competitors in a product market merge, their products converge in quality, and prices fall relative to the competition. These... View Details
Sheen, Albert. "The Real Product Market Impact of Mergers." Journal of Finance 69, no. 6 (December 2014).
- 04 Jun 2019
- Working Paper Summaries
Political Influence and Merger Antitrust Reviews
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Acquisitions (B)
By: Benjamin C. Esty and Daniel Fisher
Explores events after Impax announced the acquisition of a portfolio of generic pharmaceutical products from Teva in June 2016. View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Financial Strategy; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (B)." Harvard Business School Supplement 220-031, October 2019.
- March 1991 (Revised May 1995)
- Case
Kraft General Foods: The Merger (A)
By: David J. Collis
Describes Philip Morris' acquisitions of General Foods in 1985 and Kraft, Inc. in 1989, focusing on the integration of Kraft and General Foods that forms a $30 billion food subsidiary. Details the steps required to merge these two large companies, emphasizing the... View Details
Keywords: Mergers and Acquisitions; Business Subsidiaries; Business or Company Management; Managerial Roles; Business Processes; Cooperation; Integration; Food and Beverage Industry
Collis, David J. "Kraft General Foods: The Merger (A)." Harvard Business School Case 391-139, March 1991. (Revised May 1995.)
- October 2017 (Revised August 2020)
- Case
RB
By: Joshua Margolis, Vincent Dessain and Jerome Lenhardt
As 2016 was approaching its end, Rakesh Kapoor, CEO of RB, one of the world’s major fast moving consumer goods (FMCG) companies, envisioned the prospect of a major acquisition that would add a line of health-related products that promised growth in the developing... View Details
- June 2020
- Supplement
TransDigm: The Acquisition of Aerosonic Corp.
By: Benjamin C. Esty and Daniel W. Fisher
This courseware accompanies the case "TransDigm: The Acquisition of Aerosonic Corp." View Details
- January 2020
- Teaching Plan
Zhejiang Geely Holding Group: Acquisition of Volvo Cars and Volvo Cars: Acquisition by Geely
By: Willy Shih
This teachning plan is for the two cases 619-041 which describes Geely's acquisition of Volvo Cars, and 619-042 which describes Volvo Cars' acqusition by Geely. The case is designed to illustrate the different sides of an M&A transaction and the organizational culture... View Details
- November 2005 (Revised February 2009)
- Case
Publicis Groupe: Leading Creative Acquisitions
By: Rosabeth M. Kanter and Ryan Raffaelli
The CEO of a French-based advertising agency network led a series of high-profile acquisitions that created the world's 4th largest global communications company, after a failed strategic alliance taught him lessons about leadership and business relationships. View Details
Keywords: Mergers and Acquisitions; Leadership; Management Succession; Partners and Partnerships; Cooperation; Integration; France
Kanter, Rosabeth M., and Ryan Raffaelli. "Publicis Groupe: Leading Creative Acquisitions." Harvard Business School Case 506-010, November 2005. (Revised February 2009.)
- April 1998 (Revised July 2005)
- Case
Acquisition of Consolidated Rail Corporation (A), The
By: Benjamin C. Esty, Lori A. Flees and Mathew M Millett
On October 15, 1996, Virginia-based CSX and Pennsylvania-based Consolidated Rail (Conrail), the first and third largest railroads in the eastern United States, announced their intent to merge in a friendly deal worth $8.3 billion. This deal was part of an industry-wide... View Details
Esty, Benjamin C., Lori A. Flees, and Mathew M Millett. "Acquisition of Consolidated Rail Corporation (A), The." Harvard Business School Case 298-006, April 1998. (Revised July 2005.)
- January 2021
- Case
Takeda Pharmaceutical Company Limited (A)
By: David J. Collis, Nobuo Sato and Akiko Kanno
This case follows Christophe Weber, President and CEO of Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, as Takeda considers acquiring Shire Plc, a biotech company based in Ireland. The acquisition would turn... View Details
Keywords: Pharmaceutical Companies; Pharmaceuticals; Biotech; Biotechnology; M&A; Mergers & Acquisitions; R&D; Talent Management; Mergers and Acquisitions; Globalization; Management; Global Strategy; Talent and Talent Management; Pharmaceutical Industry; Biotechnology Industry; Japan; Asia
Collis, David J., Nobuo Sato, and Akiko Kanno. "Takeda Pharmaceutical Company Limited (A)." Harvard Business School Case 721-373, January 2021.
- September 2020 (Revised December 2020)
- Supplement
Hitachi Rail Limited (B)
By: David J. Collis, Akiko Kanno and Nobuo Sato
This supplement describes the strategy and organisation changes made by British executive, Alistair Dormer, after he is made head of Hitachi Rail's global business. The company acquires an Italian company, continues to win contracts in the UK, but struggles to bring... View Details
Keywords: Organization Structure; Leader Selection; Mergers & Acquisitions; Strategy; Global Strategy; Organizational Structure; Leadership; Mergers and Acquisitions; Integration; Values and Beliefs; Rail Industry; Japan
Collis, David J., Akiko Kanno, and Nobuo Sato. "Hitachi Rail Limited (B)." Harvard Business School Supplement 721-365, September 2020. (Revised December 2020.)
- September 1991 (Revised March 2005)
- Case
WPP Group and Its Acquisitions
By: William J. Bruns Jr.
WPP Group acquired J. Walter Thompson and Ogilvy & Mather, paying high premiums in relation to earnings. In each acquisition the goodwill acquired was immediately charged off against owners' equity. Then, WPP Group established a value for the brand names of the two... View Details
Keywords: Goodwill Accounting; Accounting; Brands and Branding; Product Positioning; Market Transactions; Equity; Private Equity; Relationships; Mergers and Acquisitions; Management Style; Consumer Products Industry; United States; United Kingdom
Bruns, William J., Jr. "WPP Group and Its Acquisitions." Harvard Business School Case 192-038, September 1991. (Revised March 2005.)
- August 2002
- Case
eBay (C): PayPal Merger
By: Frances X. Frei and Hanna Rodriguez-Farrar
Supplements the (A) case. View Details
Frei, Frances X., and Hanna Rodriguez-Farrar. "eBay (C): PayPal Merger." Harvard Business School Case 603-042, August 2002.
- February 1999
- Article
Interest-Rate Exposure and Bank Mergers
By: B. C. Esty, Bhanu Narasimhan and Peter Tufano
Esty, B. C., Bhanu Narasimhan, and Peter Tufano. "Interest-Rate Exposure and Bank Mergers." Journal of Banking & Finance 23, nos. 2-4 (February 1999): 255–285.
- March 2001 (Revised July 2004)
- Case
Adecco SA's Acquisition of Olsten Corp
In the summer of 1999, Adecco SA, one of the world's leading staffing companies, was in the midst of attempting to acquire the staffing operations of Olsten Corp., a U.S. firm. This case analyzes the economics of the staffing industry, basic valuation, cross-border... View Details
Keywords: Financial Condition; Acquisition; Cross-Cultural and Cross-Border Issues; Service Industry; United States
Kedia, Simi, and Peter Tufano. "Adecco SA's Acquisition of Olsten Corp." Harvard Business School Case 201-068, March 2001. (Revised July 2004.)
- 2009
- Other Unpublished Work
Bridge Building in Venture Capital-Backed Acquisitions
By: Paul A. Gompers and Yuhai Xuan
We study the role of common venture capital investors in alleviating asymmetric information between public acquirers and private venture capital-backed targets. We find that acquisition announcement returns are more positive for acquisitions in which both the target... View Details
Keywords: Mergers and Acquisitions; Venture Capital; Private Equity; Knowledge Sharing; Market Transactions
Gompers, Paul A., and Yuhai Xuan. "Bridge Building in Venture Capital-Backed Acquisitions." 2009.
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (B): Merger Decision
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (B): Merger Decision." Harvard Business School Supplement 806-065, January 2006. (Revised May 2007.)
- May 2014 (Revised June 2016)
- Supplement
Mylan Lab's Proposed Merger with King Pharmaceuticals—courseware
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details